Publications

Publications

Filter Results: (1,245) Arrow Down
Filter Results: (1,245) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 52 of 1,245 Results →
  • 23 Aug 2018
  • News

Healthcare Alumni Keep Learning Through Virtual Programming

pharmaceutical CEO’s perspective on what’s next in Alzheimer’s research; and a panel discussion on the digital transformation of health care. “While many other organizations might claim to offer similar topics, the VRT series is designed... View Details
Keywords: Margie Kelley; Health, Social Assistance
  • 05 Aug 2014
  • First Look

First Look: August 5

Case 614-063 Merrimack Pharmaceuticals, Inc. (A) In 2006, Merrimack Pharmaceuticals was a fast-growing biotechnology company. Its leadership team was divided over whether to keep R&D organized in functional departments or transition... View Details
Keywords: Sean Silverthorne
  • March 2024 (Revised July 2024)
  • Case

WeightWatchers: Promoting Weight Health

By: Ranjay Gulati, Cynthia A. Montgomery, Ashley Whillans, Allison Ciechanover and Emily Grandjean
In December 2023, the 60-year-old weight management industry stalwart WeightWatchers announced the launch of WeightWatchers Clinic, which incorporated GLP-1s , a new class of prescription weight-loss medications, into the company’s portfolio of products and mobile app... View Details
Keywords: Business Strategy; Competitive Strategy; Resource Allocation; Diversification; Leadership; Growth and Development Strategy; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States; New York (city, NY)
Related
  • September 2019
  • Case

Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem

By: Willy C. Shih
Vaccines for children has been a long-standing focus for the Bill & Melinda Gates Foundation, and its critical role in public health made its production an important economic and political issue. This case describes the Foundation's investment in a breakthrough vaccine... View Details
Keywords: Vaccine; Production; Supply Chain; Product; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Belgium
Related
  • December 1999
  • Case

Agrochemicals at Ciba-Geigy AG (A)

By: Michael L. Tushman, Wendy Smith and Daniel Radov
After spending five years to develop a revolutionary product, the director of Ciba-Geigy's fungicide research department is handed an unfavorable market study. The case details the R&D process for the new product, including information on corporate partnerships,... View Details
Keywords: Agribusiness; Plant-Based Agribusiness; Research and Development; Innovation and Invention; Innovation Strategy; Product Launch; Marketing Channels; Change Management; Product Development; Business Processes; Organizational Structure; Corporate Accountability; Pharmaceutical Industry; Pharmaceutical Industry
Related
  • March 2010 (Revised May 2012)
  • Case

Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration

By: Karim R. Lakhani and Paul R. Carlile
This case presents the Myelin Repair Foundation's accelerated research collaboration model for drug discovery. It highlights the challenges of building a multi-disciplinary and multi-institutional research collaboration that is attempting to create a treatment for... View Details
Keywords: Research and Development; Intellectual Property; Risk and Uncertainty; Strategic Planning; Collaborative Innovation and Invention; Health Disorders; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry
Related
  • 06 Mar 2012
  • First Look

First Look: March 6

century. It focuses especially on Beiersdorf, a pharmaceutical and skin care company in Germany. During World War I, the expropriation of its brands and trademarks revealed its vulnerability to political risk. Following the advent of the... View Details
Keywords: Sean Silverthorne
  • 28 Apr 2009
  • First Look

First Look: April 28, 2009

tilted towards old age than annuities. Several advantages of this are discussed, including some that may explain why tontines have proven popular with consumers in the past. Download the paper: http://www.hbs.edu/research/pdf/09-121.pdf   PublicationsWhere Is the... View Details
Keywords: Martha Lagace
  • 28 Oct 2014
  • First Look

First Look: October 28

Business School Case 515-007 Pfizer and AstraZeneca: Marketing an Acquisition (A) In 2014, Pfizer proposed a friendly acquisition of AstraZeneca, but the AstraZeneca board resisted over price and strategy concerns. Was this good for View Details
Keywords: Carmen Nobel
  • 15 Jan 2013
  • First Look

First Look: January 15

and Use of a New Accounting System Authors:Narayanan, V.G., Ranjani Krishnan, and Jamshed J. Mistry Publication:Journal of Management Accounting Research Abstract This study examines the attitudes, use, and acceptance of a new accounting system in a View Details
Keywords: Sean Silverthorne
  • Web

Lessons from History - Creating Emerging Markets

watched a short video of Yusuf Hamied discussing the necessity of incremental innovation in the pharmaceuticals industry in the 2000s. Lively discussion then ensued, moderated by HBS Professors Tarun Khanna, Srikant Datar, and Geoffrey... View Details
  • 27 Aug 2019
  • News

A Shot at Success

says Feickert of the Seattle Seahawks quarterback. “But most people don’t know his older brother, Harrison, was also a standout Division I football player who has had a very successful career as an entrepreneur and in the pharmaceutical... View Details
Keywords: April White
  • 21 Apr 2014
  • Research & Ideas

Bio-Piracy: When Western Firms Usurp Eastern Medicine

communities that traditionally use the herb. The paper cites two key examples of local communities benefiting from a firm's herbal patent. In one case, members of Indian Kani tribe received royalties for the pharmaceutical version of the... View Details
Keywords: by Carmen Nobel; Legal Services; Biotechnology
  • 10 Jun 2008
  • First Look

First Look: June 10, 2008

Formula’ Harvard Business School Case 808-127 Robert Wessman took over Actavis in 1999 when it was a failing 90-person domestic generic pharmaceutical maker in Iceland. Within 7 years he had brought Actavis to number 5 worldwide, with... View Details
Keywords: Martha Lagace
  • 05 Jul 2004
  • Research & Ideas

Radical Change, Entrepreneurial Opportunity

tightly coupled relationships with customers to engage in trials of different product concepts, producers and users can jointly learn about and make sense of the new technology. For instance, Surface Logix, a firm with highly sophisticated, flexible technology called... View Details
Keywords: by Michael J. Roberts; Technology
  • 13 Oct 2016
  • News

Adding Muscle to the Fight Against Disease

Stanford, in addition to his Harvard MBA, Blum’s credentials make him well suited to a career in biotech. Prior to joining Cytokinetics, he had experience in sales, marketing, and business development in large and small pharmaceutical... View Details
Keywords: Deborah Blagg
  • 10 Jun 2021
  • Blog Post

Managing Sustainable Advantage with Key ESG Cofounders, Anne-Marie Schoonbeek and Heleen van Poecke

internship and then later back to McKinsey after graduation, where she focused on both large-cap and startups in the pharmaceuticals and biotech space. “For me, this was a way of making an impact,” said Schoonbeek. van Poecke began her... View Details
  • 22 Oct 2013
  • First Look

First Look: October 22

expenditures on teammates lead to better performance in both sports teams in Canada and pharmaceutical sales teams in Belgium. These results suggest that a minor adjustment to employee bonuses-shifting the focus from the self to... View Details
Keywords: Sean Silverthorne
  • Web

Souvenirs & Novelties - The Art of American Advertising

distribute them and local retailers to print their names on them at no cost. James C. Ayer, involved in the pharmaceutical industry, reaped enormous publicity benefits from the distribution of yearly almanacs. Ayer eventually established... View Details
  • 14 May 2014
  • News

(Re)moving the Needle

that of his father, who was trained as an engineer and ended up in the pharmaceutical industry. He holds MSc and PhD degrees in mechanical engineering from ETH Zurich and MIT, respectively, and he spent a year pursuing advanced studies in... View Details
Keywords: Robert S. Benchley; medical technology; Scientific Research and Development Services